NCT05021562Completed
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Zedula Special Drug Use Observational Study "Ovarian Cancer"
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The main aim of this study is to check for side effects from treatment with niraparib. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with ovarian cancer will take capsules of niraparib (Zedula) once a day according to their clinic's standard practice. The study doctors will check for side effects from niraparib for 1 year after treatment starts.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 354 (actual)
- First submitted
- 24 Aug 2021
- Start date
- 13 Sept 2021
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Takeda
- Diseases
- Ovarian cancer, Childhood cancers
- NCT number
- NCT05021562
What you commit to
- Study type: Observational
- Participants enrolled: 354
- From 13 Sept 2021 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has a history of hypersensitivity to any of the ingredients of this drug.
Who the study is looking for
- An individual who corresponds to any of the following:
- Ovarian cancer patients after initial chemotherapy (maintenance therapy)
- Patients with platinum antineoplastic drug sensitive recurrent ovarian cancer (maintenance therapy)
- Recurrent ovarian cancer with platinum-sensitive homologous recombination repair defects.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.